Ajanta Pharma share news and announcements
NSE: AJANTPHARMBSE: 532331Pharmaceuticals & BiotechnologyMid Cap
Last close ₹3,283.90up ₹13.30 (0.41%)BSE ₹3,281.15
Share price at the NSE close on 23 Oct 2026. Previous close ₹3,270.60.
52-week range of traded prices to 23 Oct 2026
₹2,382.00Low, 28 Oct 2025₹3,796.00High, 18 Aug 2026
- Next results date: the board meets on 30 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹41,035 Cr236th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 30 Jul 2026
- 36.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 5 May 2026
- 9.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.83%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 30 Jul 2026
- 27.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 30 Jul 2026
- 27.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 5 May 2026
- 0.05
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,54,84762.5% delivered
Next board meeting and results date
As the company gave notice to the exchange.Ajanta Pharma quarterly results
Oct30Fri
The board meets on 30 Oct 2026 to consider financial results
Notice filed 15 Oct 2026
Ajanta Pharma annual reports, presentations and earnings calls
The company's own documents, latest first.Ajanta Pharma financials, year by year
Annual reports16
- Annual report, year to Mar 2026 (opens in a new tab)18 Jun 2026
- Annual report, year to Mar 2025 (opens in a new tab)18 Jun 2025
- Annual report, year to Mar 2024 (opens in a new tab)6 Sep 2024
- Annual report, year to Mar 2023 (opens in a new tab)16 Jun 2023, a zip file
- Annual report, year to Mar 2022 (opens in a new tab)6 Jul 2022, a zip file
11 earlier reports
- Annual report, year to Mar 2021 (opens in a new tab)15 Jun 2021, a zip file
- Annual report, year to Mar 2020 (opens in a new tab)30 Jun 2020, a zip file
- Annual report, year to Mar 2019 (opens in a new tab)20 Jun 2019, a zip file
- Annual report, year to Mar 2018 (opens in a new tab)5 Jul 2018, a zip file
- Annual report, year to Mar 2017 (opens in a new tab)5 Jul 2017, a zip file
- Annual report, year to Mar 2016 (opens in a new tab)5 Jul 2016, a zip file
- Annual report, year to Mar 2015 (opens in a new tab)10 Jun 2015, a zip file
- Annual report, year to Mar 2014 (opens in a new tab)4 Jul 2014, a zip file
- Annual report, year to Mar 2013 (opens in a new tab)27 Jun 2013, a zip file
- Annual report, year to Mar 2012 (opens in a new tab)22 Jun 2012, a zip file
- Annual report, year to Mar 2010 (opens in a new tab)8 Apr 2011, a zip file
Investor presentations15
- Investor Presentation (opens in a new tab)5 Feb 2020
- Investor Presentation (opens in a new tab)5 Nov 2019
- Investor Presentation (opens in a new tab)31 Jul 2019
- Investor Presentation (opens in a new tab)30 Apr 2019
- Investor Presentation (opens in a new tab)30 Jan 2019
10 earlier presentations
- Investor Presentation (opens in a new tab)31 Oct 2018
- Investor Presentation (opens in a new tab)31 Jul 2018, a zip file
- Investor Presentation (opens in a new tab)2 May 2018, a zip file
- Investor Presentation for Q3 2018 (opens in a new tab)25 Jan 2018, a zip file
- Investor Presentation (opens in a new tab)31 Oct 2017, a zip file
- Investor Presentation (opens in a new tab)9 Aug 2017, a zip file
- Investor Presentation (opens in a new tab)3 May 2017, a zip file
- Investor Presentation (opens in a new tab)24 Jan 2017, a zip file
- Presentation on results being circulated to the investors and analysts. (opens in a new tab)26 Oct 2016, a zip file
- Presentation on results being circulated to the investors and analysts. (opens in a new tab)26 Jul 2016, a zip file
Earnings calls42
- Transcript (opens in a new tab)3 Aug 2026
- Link of Recording (opens in a new tab)30 Jul 2026
- Transcript (opens in a new tab)8 May 2026
- Link of Recording (opens in a new tab)5 May 2026
- Transcript (opens in a new tab)5 Feb 2026
37 earlier call documents
- Link of Recording (opens in a new tab)30 Jan 2026
- Transcript (opens in a new tab)6 Nov 2025
- Link of Recording (opens in a new tab)3 Nov 2025
- Transcript (opens in a new tab)31 Jul 2025
- Link of Recording (opens in a new tab)28 Jul 2025
- Transcript (opens in a new tab)5 May 2025
- Link of Recording (opens in a new tab)30 Apr 2025
- Transcript (opens in a new tab)3 Feb 2025
- Link of Recording (opens in a new tab)30 Jan 2025
- Transcript (opens in a new tab)30 Oct 2024
- Link of Recording (opens in a new tab)28 Oct 2024
- Transcript (opens in a new tab)2 Aug 2024
- Link of Recording (opens in a new tab)30 Jul 2024
- Transcript (opens in a new tab)8 May 2024
- Link of Recording (opens in a new tab)2 May 2024
- Transcript (opens in a new tab)5 Feb 2024
- Link of Recording (opens in a new tab)31 Jan 2024
- Transcript (opens in a new tab)3 Nov 2023
- Link of Recording (opens in a new tab)31 Oct 2023
- Link of Recording (opens in a new tab)31 Oct 2023
- Transcript (opens in a new tab)2 Aug 2023
- Link of Recording (opens in a new tab)27 Jul 2023
- Transcript (opens in a new tab)11 May 2023
- Link of Recording (opens in a new tab)5 May 2023
- Transcript (opens in a new tab)13 Feb 2023
- Link of Recording (opens in a new tab)2 Feb 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call (opens in a new tab)10 Nov 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call (opens in a new tab)4 Nov 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call (opens in a new tab)3 Aug 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call (opens in a new tab)29 Jul 2022
- Written transcript of the earnings call held on 10th May 2022 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link http://www.ajantapharma.com/AdminData/Results/EarningsC allTranscriptQ4(Jan-Mar)2021-22.pdf (opens in a new tab)14 May 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call conducted on 10th May 2022 (opens in a new tab)11 May 2022
- Transcript (opens in a new tab)4 Feb 2022
- Audio call recording of the earnings call held on 31st January 2022 at 5.00 p.m. has been uploaded on the Company s website and can be accessed through the link:http://www.ajantapharma.com/AdminData/Results/EarningsCallAudioQ3(Oct-Dec)2021-22.mp3 (opens in a new tab)31 Jan 2022
- Transcript (opens in a new tab)8 Nov 2021
- Transcript (opens in a new tab)8 Nov 2021
- Link of Recording of Earnings call (opens in a new tab)29 Oct 2021
Ajanta Pharma share news and announcements
815 announcements, routine notices left out, newest first. Page 1 of 17.
Oct 2026
15 Oct · Analysts
Sep 2026
30 Sep · General Updates
Aug 2026
31 Aug · Analysts
File name: “Investorparticipation31082026”
5 Aug · Analysts
Jul 2026
30 Jul · General Updates
30 Jul · Corporate action
21 Jul · Analysts
20 Jul · Analysts
Jun 2026
15 Jun · General Updates
12 Jun · Analysts
May 2026
19 May · Analysts
19 May · Analysts
Apr 2026
21 Apr · Analysts
Mar 2026
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts).
- 30 Jul 2026Resultsup 1.17%+1.2 pts vs Nifty 500market median −0.7% · five sessions +1.2% (−0.4 pts vs Nifty 500) · volume 4.3× usual · delivery −30.9 pts against usual · The announcement (opens in a new tab)
- 5 May 2026Resultsdown 0.11%0.0 pts vs Nifty 500market median −0.7% · five sessions +5.6% (+5.8 pts vs Nifty 500) · volume 1.0× usual · delivery −6.5 pts against usual · The announcement (opens in a new tab)
- 30 Jan 2026Resultsup 3.23%+3.5 pts vs Nifty 500market median −0.7% · five sessions +4.7% (+3.0 pts vs Nifty 500) · volume 1.2× usual · delivery −13.7 pts against usual · The announcement (opens in a new tab)
- 3 Nov 2025Resultsup 3.01%+2.6 pts vs Nifty 500market median −0.7% · five sessions +2.6% (+3.1 pts vs Nifty 500) · volume 2.0× usual · delivery −39.0 pts against usual · The announcement (opens in a new tab)
- 28 Jul 2025Resultsdown 0.62%+0.1 pts vs Nifty 500market median −0.7% · five sessions −3.2% (−1.7 pts vs Nifty 500) · volume 1.1× usual · delivery −21.2 pts against usual · The announcement (opens in a new tab)
- 30 Apr 2025Resultsdown 2.16%−1.8 pts vs Nifty 500market median −0.7% · five sessions −9.7% (−9.5 pts vs Nifty 500) · volume 1.0× usual · delivery +9.1 pts against usual · The announcement (opens in a new tab)
- 31 Jan 2025Resultsup 0.66%−0.7 pts vs Nifty 500market median −0.7% · five sessions +4.1% (+1.8 pts vs Nifty 500) · volume 2.5× usual · delivery +32.3 pts against usual · The announcement (opens in a new tab)
- 29 Oct 2024Dividendup 0.06%−0.6 pts vs Nifty 500market median 0.0% · five sessions +2.1% (+2.7 pts vs Nifty 500) · volume 0.8× usual · delivery −24.5 pts against usual · The announcement (opens in a new tab)
- 30 Jul 2024Resultsup 4.63%+4.4 pts vs Nifty 500market median −0.7% · five sessions +17.5% (+21.1 pts vs Nifty 500) · volume 2.4× usual · delivery −31.6 pts against usual · The announcement (opens in a new tab)
- 18 Jul 2024Board or managers changedup 2.57%+2.5 pts vs Nifty 500market median 0.0% · five sessions +7.0% (+8.3 pts vs Nifty 500) · volume 0.6× usual · delivery −17.3 pts against usual · The announcement (opens in a new tab)
20 earlier announcements
- 28 Jun 2024Buybackup 0.15%+0.1 pts vs Nifty 500market median 0.0% · five sessions −2.8% (−4.5 pts vs Nifty 500) · volume 0.6× usual · delivery +15.1 pts against usual · The announcement (opens in a new tab)
- 21 Jun 2024Buybackup 0.21%+0.5 pts vs Nifty 500market median 0.0% · five sessions −2.4% (−3.5 pts vs Nifty 500) · volume 0.5× usual · delivery +10.3 pts against usual · The announcement (opens in a new tab)
- 4 Jun 2024Buybackdown 1.53%+5.2 pts vs Nifty 500market median 0.0% · five sessions +3.8% (+3.7 pts vs Nifty 500) · volume 1.4× usual · delivery −7.0 pts against usual · The announcement (opens in a new tab)
- 7 May 2024Buybackdown 0.69%+0.4 pts vs Nifty 500market median 0.0% · five sessions −1.4% (+0.3 pts vs Nifty 500) · volume 0.8× usual · delivery −13.5 pts against usual · The announcement (opens in a new tab)
- 3 May 2024Resultsup 6.71%+7.3 pts vs Nifty 500market median −0.7% · five sessions +7.9% (+11.4 pts vs Nifty 500) · volume 29.2× usual · delivery −42.0 pts against usual · The announcement (opens in a new tab)
- 1 Feb 2024Dividendup 0.32%+0.4 pts vs Nifty 500market median 0.0% · five sessions +3.8% (+2.3 pts vs Nifty 500) · volume 4.8× usual · delivery −11.6 pts against usual · The announcement (opens in a new tab)
- 28 Jul 2023Dividendup 4.07%+3.9 pts vs Nifty 500market median 0.0% · five sessions +10.9% (+11.8 pts vs Nifty 500) · volume 17.4× usual · delivery −45.8 pts against usual · The announcement (opens in a new tab)
- 8 May 2023Resultsdown 1.52%−2.5 pts vs Nifty 500market median −0.7% · five sessions −2.7% (−4.0 pts vs Nifty 500) · volume 2.9× usual · delivery +25.8 pts against usual · The announcement (opens in a new tab)
- 20 Apr 2023Buybackdown 0.14%−0.2 pts vs Nifty 500market median 0.0% · five sessions −1.2% (−2.2 pts vs Nifty 500) · volume 0.9× usual · delivery +22.6 pts against usual · The announcement (opens in a new tab)
- 28 Mar 2023Buybackdown 1.26%−0.9 pts vs Nifty 500market median 0.0% · five sessions +7.5% (+4.3 pts vs Nifty 500) · volume 0.3× usual · delivery −16.3 pts against usual · The announcement (opens in a new tab)
- 14 Mar 2023Buybackdown 0.71%0.0 pts vs Nifty 500market median 0.0% · five sessions −3.0% (−2.0 pts vs Nifty 500) · volume 0.5× usual · delivery −5.0 pts against usual · The announcement (opens in a new tab)
- 4 Nov 2022Dividenddown 6.79%−7.1 pts vs Nifty 500market median 0.0% · five sessions −6.7% (−7.7 pts vs Nifty 500) · volume 7.0× usual · delivery −22.5 pts against usual · The announcement (opens in a new tab)
- 28 Feb 2022Buybackdown 0.88%−1.7 pts vs Nifty 500market median 0.0% · five sessions −1.8% (+2.6 pts vs Nifty 500) · volume 3.3× usual · delivery +29.3 pts against usual · The announcement (opens in a new tab)
- 21 Jan 2022Buybackup 2.87%+4.0 pts vs Nifty 500market median 0.0% · five sessions +1.2% (+5.3 pts vs Nifty 500) · volume 0.7× usual · delivery −15.0 pts against usual · The announcement (opens in a new tab)
- 5 Jan 2022Buybackup 1.38%+0.9 pts vs Nifty 500market median 0.0% · five sessions +3.5% (+2.1 pts vs Nifty 500) · volume 0.8× usual · delivery −19.0 pts against usual · The announcement (opens in a new tab)
- 31 Dec 2021Buybackdown 1.21%−2.2 pts vs Nifty 500market median 0.0% · five sessions −1.5% (−4.5 pts vs Nifty 500) · volume 0.6× usual · delivery +6.2 pts against usual · The announcement (opens in a new tab)
- 28 Dec 2021Buybackup 3.95%+3.0 pts vs Nifty 500market median 0.0% · five sessions +1.6% (−1.6 pts vs Nifty 500) · volume 8.0× usual · delivery −31.6 pts against usual · The announcement (opens in a new tab)
- 28 Dec 2020Buybackup 1.02%+0.1 pts vs Nifty 500market median 0.0% · five sessions −1.3% (−3.5 pts vs Nifty 500) · volume 0.9× usual · delivery −3.3 pts against usual · The announcement (opens in a new tab)
- 26 Nov 2020Buybackup 0.03%−0.9 pts vs Nifty 500market median 0.0% · five sessions +2.2% (−0.8 pts vs Nifty 500) · volume 0.9× usual · delivery −16.1 pts against usual · The announcement (opens in a new tab)
- 11 Nov 2020Buybackup 1.36%+0.5 pts vs Nifty 500market median 0.0% · five sessions +1.4% (−1.0 pts vs Nifty 500) · volume 1.3× usual · delivery +10.6 pts against usual · The announcement (opens in a new tab)
Ajanta Pharma results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.